XenoMEM - Model ECM - Extracellular Matrix
From Uniquely Developed Platforms
XenoMEM™ extracellular matrix is a robust biologic matrix consisting primarily of type I, type III, and type IV collagens and contains additional extracellular matrix proteins. XenoMEM is derived from porcine peritoneal membrane, and it is decellularized and lyophilized to yield a shelf stable component that provides a structure for soft tissue restoration and healing. Viscus Biologics has several xenograft ECM product platforms to support design service and original design manufacturing activities.
-
Most popular related searches
Benefits
ECM product platforms offer the following features and benefits:
- Retain native molecules, growth factors, and mechanical properties.
- Offer temporary structural support.
- Enhance the biochemical environment to promote remodeling and healing of tissues and wounds.
- Facilitate the recruitment of multipotential stem/progenitor cells to the site of interest.
- Robust decellularization process reduces material immunogenicity.
- Peer reviewed publications and company testing support application development.
Customer reviews
No reviews were found for XenoMEM - Model ECM - Extracellular Matrix. Be the first to review!